Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Clauß, Julian (1) Costanza, Mariantonia Dr. (1) Daniel, Peter Prof. Dr. (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (5) Kieback, Elisa Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Na, Il-Kang Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (14) (-) Wollert-Wulf, Brigitte (2) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (2) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genom-Editierung & Krankheitsmodelle (1) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (1) Integrative Vaskuläre Biologie (1) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (14) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Pluripotent Stem Cells (1) Proteom Dynamik (8) Proteomics (1) Proteomics and Metabolomics (1) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (1) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (3) 2015 (4) 2016 (4) 2017 (6) (-) 2018 (4) 2019 (7) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 16 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199720062018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling 30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky 01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel 01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling
30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein